Clinical trial NCT03670433: Medication Reconciliation for Patients Over 65 Years Old : Cost Analysis of the Process Implemented in the Polyvalent Internal Medical Unit of Rennes University Hospital
Official title: Medication Reconciliation for Patients Over 65 Years Old : Cost Analysis of the Process Implemented in the Polyvalent Internal Medical Unit of Rennes University Hospital
Study type: OBSERVATIONAL
Overall status: COMPLETED
Conditions: Medication Reconciliation
Keywords: Medication reconciliation
Care path
Prevention
Lead sponsor: Rennes University Hospital
Sponsor class: OTHER
First posted: 2018-09-13
Enrollment: 100
Sex: ALL
Minimum age (years): 65
Standard ages: OLDER_ADULT
Accepts healthy volunteers: no
Observational model: COHORT
Time perspective: PROSPECTIVE
Sampling method: NON_PROBABILITY_SAMPLE
Study population: Patients over 65 years admitted at the UMIP of Rennes University Hospital between 09/04/2017 and 10/31/2017.

Brief summary: Among the strategies to secure the patient's care path, medication reconciliation is a powerful approach for the prevention and interception of medication errors.

Detailed description: All medication errors are not serious. Nevertheless 4 studies show that respectively 5.6%, 5.7%, 6.3% and 11.7% of the medication errors intercepted by medication reconciliation (MR) could have had major, critical or catastrophic consequences for patients. If the consequences of a medication error have a clinical or institutional translation for the patient, they can also directly impact the hospital or caregivers, for example by extending the average length of stay or by increasing the number of consultations or readmissions.

The efficiency of the medication reconciliation approach has never been evaluated in France in comparison with standard care. Before initiating cost-effectiveness studies, we propose to conduct a micro-costing study to evaluate the production costs of this conciliation approach.

The costs are almost exclusively related to human resources and the present study will assess the time spent by the different actors involved in the process.

Eligibility criteria: Inclusion Criteria:

* Patients over 65 years old
* Patient non-institutionalized at entry
* For MR :

  * Entry : patients admitted at UMIP between 09/04/2017 and 10/31/2017
  * Discharge : patients returning home or going to a rehabilitation service between 04/09/2017 and 31/10/2017 and having received MR evaluation

Exclusion Criteria:

* Patients not returning home
* Refusal of participation
* Major persons subject to legal protection (safeguard of justice, guardianship), persons deprived of their liberty

Primary outcomes:
measure: Time spent by professionals
timeFrame: At the inclusion day
measure: Average cost of MR process
timeFrame: At the inclusion day
measure: Number of unintentional discrepancies detected
timeFrame: At the inclusion day
measure: Severity of unintentional discrepancies detected
timeFrame: At the inclusion day
Secondary outcomes:
Other outcomes:
Locations:
city: Rennes
country: France
facility: Rennes University Hospital
Study officials:
affiliation: Rennes University Hospital
name: Berengere CADOR, MD
role: PRINCIPAL_INVESTIGATOR
References: